Metabolic deterioration accelerates 1 year to 6 months prior to Stage 3 T1D onset, with marked declines in beta cell glucose sensitivity, rate sensitivity and potentiation coupled with decreased insulin sensitivity, and markedly rising blood glucose levels (Ferrannini et al. 2010, Evans-Molina et al. 2018). The gene discussed is INS; the disease is type 1 diabetes mellitus.